Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 Post author:Sam Post published:January 31, 2018 Post category:BioPharma Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace You Might Also Like VEXIM Acquired by Stryker in EUR 183M Deal October 24, 2017 AbbVie Wins FDA Approval for the First-Ever Drug to Treat All Forms of Hep C August 3, 2017 Optimized Sensors To Study Learning And Memory, Study March 9, 2017